Developer docs
API playgroundTry for free, no card

Search company profiles

Temple

Full company profile

uuid00stvo1

Namestring
Temple
Legal namestring
Temple Wearables Inc.
Websiteurl
temple.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Temple is a privately held, pre-revenue wearable-technology startup founded in August 2024 by Deepinder Goyal (co-founder and former CEO of Zomato/Eternal), developing a head-worn device that non-invasively reads signals from the superficial temporal artery to compute a proprietary biomarker called 'Entropy' — a real-time 1-250 score representing the body's metabolic and sympathetic demand, with sub-scores for Entropy Maxima (peak capacity) and Entropy Minima (resting metabolic cost). The company claims a correlation of r=0.93 between Entropy readings and laboratory-grade calorimeters across more than 100 cardio sessions, versus r=0.55 for heart rate, and positions the forehead/temple sensing site as structurally superior to wrist-based wearables due to thinner skin, higher vascularization, and lower motion interference. The product is anchored by founder Goyal's 'Gravity Ageing Hypothesis' linking gravitational stress on brain circulation to aging, supported by an 8-member Scientific Advisory Board drawn from Boston University, Harvard Medical School, Massachusetts General Hospital, Salk Institute, EPFL, University of Ottawa, University of Florida, and Vrije Universiteit Amsterdam.

Temple's business model combines one-time hardware sales through a direct-to-consumer channel (temple.com) with a planned recurring subscription layer, currently operationalized as an invite-only Early Access Program in which selected beta users pay an undisclosed amount that will be discounted from the eventual commercial subscription price. The first 100 devices shipped in May 2026 to a curated founding cohort of athletes, scientists, founders, doctors, and creators, following a $54M friends-and-family seed round in February 2026 at a ~$190M post-money valuation — among India's largest seed rounds — with manufacturing outsourced to Zetwerk and Ethereal Machines. The product roadmap extends beyond Entropy into brain-computer interface (BCI), EEG/EMG sensing, and broader cerebral blood flow monitoring, with companion-app integrations including Apple Health, Google Sign-In, and a third-party-LLM-powered personalized AI assistant. As of mid-2026 the company has not announced a commercial launch date, pricing, or public availability, and the technology remains unvalidated by independent peer review.

Short descriptiontext

Temple is a pre-revenue wearable startup founded by Deepinder Goyal that builds a head-worn device reading a proprietary 'Entropy' metabolic biomarker from the superficial temporal artery, targeting elite athletes and high-performance professionals through a direct-to-consumer model with planned subscription pricing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersNew Delhi, India
HQ citystring
New Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
wearable health devices, cerebral blood flow monitoring, biosignal analytics, fitness wearables, brain-computer interfaces
Industry3 codes
PRIMARYCRACAIAG
Sleep Tech Wearables
SECONDARYCRACAQAH
Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Wearable Health Technology
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Device hardware sales
TypeHardware Sales
Description

Temple sells its wearable device (Temple Wearables Inc.) to end-user customers for personal, non-commercial use only. First batch of around 100 units has shipped as a beta program; the company is targeting initial production of a few thousand units for both Indian and overseas markets including the US. No commercial launch date or pricing has been publicly disclosed.

financialexpress.com
2Subscription Services
TypeSubscription Recurring
Description

Temple references an 'overall subscription price of the Services' and a beta device payment that will be discounted from the subscription price upon commercial launch, indicating a planned recurring subscription revenue model alongside device sales.

temple.com
3Beta device program fees
TypeOne Time License
Description

Selected early access applicants must complete payment for the Beta Device via a payment link; the amount paid will be discounted from the eventual commercial subscription price, serving as an early pre-order mechanism.

temple.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Pricing details1 tier
1Beta / Early Access Device
ModelOtherBilling cadenceOne time/ perpetual license
Notes

Pricing not disclosed publicly; selected early access applicants complete payment via a payment link shared by Temple, with the amount discounted from the eventual commercial subscription price.

economictimes.indiatimes.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Temple Wearable
Description

The head-worn wearable device that continuously measures cerebral blood flow and introduces the proprietary 'Entropy' biomarker.

deccanherald.com
+1 more record
Core offering1 text field

Temple develops a head-worn (temple/forehead) wearable device that non-invasively reads the proprietary Entropy biomarker from the superficial temporal artery, quantifying real-time metabolic and sympathetic demand on a 1–250 scale. The hardware is paired with a companion mobile application that visualizes Entropy, heart rate, sleep, recovery and other metrics, integrates with Apple Health, and offers an AI-assisted chat for personalized insights.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Temple offers a single integrated product line built around the head-worn Temple Wearable Device, the proprietary Entropy biomarker it computes, and the companion Temple Mobile Application. The wearable reads signals non-invasively from the superficial temporal artery and outputs the Entropy score (1–250), including Entropy Maxima and Entropy Minima sub-scores, while the Temple Mobile Application handles onboarding, account and payment management, AI-assisted chat, and synchronization with Apple Health and other connected services. The Early Access Program is the launch vehicle for the device, distributing the first 100 units to a curated founding cohort ahead of wider commercial availability. Together the device, app, Entropy metric, and Early Access Program form a unified single-product architecture aimed at elite athletes and high-performance professionals.

Product and service4 records
1Temple Wearable Device
CategoryCore Product / Wearable Hardware
Description

Head-worn (temple/forehead) wearable that non-invasively reads signals from the superficial temporal artery to compute and display the proprietary Entropy biomarker (1–250 score) representing real-time metabolic and sympathetic demand, along with heart rate, recovery, sleep and cerebral blood flow metrics. Targeted at elite athletes and high-performance professionals.

2Temple Mobile Application
CategoryCompanion Software
Description

Companion mobile app that pairs with the Temple wearable for onboarding, account and payment management, display of Entropy and other wellness metrics, AI-assisted chat, and synchronization with Apple Health.

3Entropy Biomarker
CategoryProprietary Metric / Software Feature
Description

Proprietary wellness biomarker quantifying the real-time metabolic cost of being alive, displayed as a live score from 1 to 250 updated every second, with Entropy Maxima (peak physical capacity) and Entropy Minima (resting metabolic cost) sub-scores.

4Temple Subscription Services
CategorySubscription Service
Description

Planned recurring subscription service accompanying the Temple device experience, referenced in the Terms of Use; the beta device payment is applied as a discount toward the eventual commercial subscription price.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Polar
TypeDirect peer
Description

Heart rate and performance wearable brand frequently cited in Temple's accuracy benchmarks (e.g., the badminton test). Directly comparable on accuracy-centric positioning in elite sport and the same target buyer profile.

TypeDirect peer
Description

Head-worn brain-sensing wearable (EEG) for meditation, sleep, and focus. Comparable to Temple on head-worn form factor, brain-focused biometrics, and consumer neurotechnology category, with overlap in the 'preventive/cognitive health' value proposition.

TypeOthers
Description

Failed consumer hardware startup that illustrates the risks of premium, design-forward hardware without a clear validated use case. Comparable as a cautionary structural peer for Temple's premium consumer hardware business model and fundraising scale.

TypeBroad incumbent
Description

Established performance wearables portfolio with deep penetration among elite and endurance athletes. Comparable on target customer (elite athletes including PV Sindhu's broader category) and accuracy validation culture, and a key competitor for sport-specific adoption.

TypeDirect peer
Description

Subscription-based wrist wearable focused on recovery, strain, and sleep for athletes and high-performance users. Directly comparable to Temple in target customer (elite performance), wearable-with-subscription business model, and emphasis on proprietary recovery/biomarker metrics rather than step counting.

TypeEmerging player
Description

Brain-computer interface company building EEG-based wearables for productivity and health. Comparable to Temple on neurotechnology/Brain-Computer Interface focus and the same recruiting areas (neural sensing, EEG).

TypeRegional player
Description

India-based smart ring and metabolic health wearable startup with a premium performance positioning. Comparable as a fellow Indian premium wearable brand targeting high-performance users with proprietary biomarkers; competes in the same Indian premium consumer segment.

8Cranialis
TypeEmerging player
Description

Emerging consumer neurotechnology startup developing head-worn devices for cognitive performance. Thematically adjacent to Temple on head-worn form factor and brain-performance biometrics.

TypeBroad incumbent
Description

Dominant wrist-worn wearable with health sensors (HR, HRV, SpO2, ECG) and deep Apple Health integration. Represents the incumbent Temple must displace or differentiate from, particularly given Temple's Apple Health sync compatibility.

TypeDirect peer
Description

Smart ring with subscription that delivers proprietary readiness, sleep, and recovery scores for performance-oriented consumers. Comparable to Temple in hardware-plus-subscription model, proprietary biomarker framing, and premium consumer positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Temple

Wearable Health Technologytemple.com

Temple is a pre-revenue wearable startup founded by Deepinder Goyal that builds a head-worn device reading a proprietary 'Entropy' metabolic biomarker from the superficial temporal artery, targeting elite athletes and high-performance professionals through a direct-to-consumer model with planned subscription pricing.

What Temple does

Temple is a privately held, pre-revenue wearable-technology startup founded in August 2024 by Deepinder Goyal (co-founder and former CEO of Zomato/Eternal), developing a head-worn device that non-invasively reads signals from the superficial temporal artery to compute a proprietary biomarker called 'Entropy' — a real-time 1-250 score representing the body's metabolic and sympathetic demand, with sub-scores for Entropy Maxima (peak capacity) and Entropy Minima (resting metabolic cost). The company claims a correlation of r=0.93 between Entropy readings and laboratory-grade calorimeters across more than 100 cardio sessions, versus r=0.55 for heart rate, and positions the forehead/temple sensing site as structurally superior to wrist-based wearables due to thinner skin, higher vascularization, and lower motion interference. The product is anchored by founder Goyal's 'Gravity Ageing Hypothesis' linking gravitational stress on brain circulation to aging, supported by an 8-member Scientific Advisory Board drawn from Boston University, Harvard Medical School, Massachusetts General Hospital, Salk Institute, EPFL, University of Ottawa, University of Florida, and Vrije Universiteit Amsterdam.

Temple's business model combines one-time hardware sales through a direct-to-consumer channel (temple.com) with a planned recurring subscription layer, currently operationalized as an invite-only Early Access Program in which selected beta users pay an undisclosed amount that will be discounted from the eventual commercial subscription price. The first 100 devices shipped in May 2026 to a curated founding cohort of athletes, scientists, founders, doctors, and creators, following a $54M friends-and-family seed round in February 2026 at a ~$190M post-money valuation — among India's largest seed rounds — with manufacturing outsourced to Zetwerk and Ethereal Machines. The product roadmap extends beyond Entropy into brain-computer interface (BCI), EEG/EMG sensing, and broader cerebral blood flow monitoring, with companion-app integrations including Apple Health, Google Sign-In, and a third-party-LLM-powered personalized AI assistant. As of mid-2026 the company has not announced a commercial launch date, pricing, or public availability, and the technology remains unvalidated by independent peer review.

Temple firmographics

Firmographics
Name
Temple
Legal name
Temple Wearables Inc.
Website
https://temple.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
251–500 employees
Short description
Temple is a pre-revenue wearable startup founded by Deepinder Goyal that builds a head-worn device reading a proprietary 'Entropy' metabolic biomarker from the superficial temporal artery, targeting elite athletes and high-performance professionals through a direct-to-consumer model with planned subscription pricing.
Ownership category
akta.pro rank

Temple industry classification

Industry
Product category
Wearable Health Technology
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYCRACAIAG
Sleep Tech Wearables
SECONDARYCRACAQAH
Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Wearable health devices
  • Cerebral blood flow monitoring
  • Biosignal analytics
  • Fitness wearables
  • Brain-computer interfaces

Where Temple is headquartered

Location

Headquarters

HQ city
New Delhi
HQ country
India
HQ region
Asia

Offices2 records

Markets served

Temple business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Device hardware sales: Temple sells its wearable device (Temple Wearables Inc.) to end-user customers for personal, non-commercial use only. First batch of around 100 units has shipped as a beta program; the company is targeting initial production of a few thousand units for both Indian and overseas markets including the US. No commercial launch date or pricing has been publicly disclosed.
  2. Subscription Services: Temple references an 'overall subscription price of the Services' and a beta device payment that will be discounted from the subscription price upon commercial launch, indicating a planned recurring subscription revenue model alongside device sales.
  3. Beta device program fees: Selected early access applicants must complete payment for the Beta Device via a payment link; the amount paid will be discounted from the eventual commercial subscription price, serving as an early pre-order mechanism.

Pricing tiers

ModelBillingPrice
OtherOne time/ perpetual licenseBeta / Early Access Device

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Temple product offering

Product offering

Core offering

Temple develops a head-worn (temple/forehead) wearable device that non-invasively reads the proprietary Entropy biomarker from the superficial temporal artery, quantifying real-time metabolic and sympathetic demand on a 1–250 scale. The hardware is paired with a companion mobile application that visualizes Entropy, heart rate, sleep, recovery and other metrics, integrates with Apple Health, and offers an AI-assisted chat for personalized insights.

Product overview

Temple offers a single integrated product line built around the head-worn Temple Wearable Device, the proprietary Entropy biomarker it computes, and the companion Temple Mobile Application. The wearable reads signals non-invasively from the superficial temporal artery and outputs the Entropy score (1–250), including Entropy Maxima and Entropy Minima sub-scores, while the Temple Mobile Application handles onboarding, account and payment management, AI-assisted chat, and synchronization with Apple Health and other connected services. The Early Access Program is the launch vehicle for the device, distributing the first 100 units to a curated founding cohort ahead of wider commercial availability. Together the device, app, Entropy metric, and Early Access Program form a unified single-product architecture aimed at elite athletes and high-performance professionals.

Differentiator

Problem solved

Functional benefit

Brands

  • Temple Wearable: The head-worn wearable device that continuously measures cerebral blood flow and introduces the proprietary 'Entropy' biomarker.
  • Entropy

Products and services

  • Temple Wearable Device Head-worn (temple/forehead) wearable that non-invasively reads signals from the superficial temporal artery to compute and display the proprietary Entropy biomarker (1–250 score) representing real-time metabolic and sympathetic demand, along with heart rate, recovery, sleep and cerebral blood flow metrics. Targeted at elite athletes and high-performance professionals.
  • Temple Mobile Application Companion mobile app that pairs with the Temple wearable for onboarding, account and payment management, display of Entropy and other wellness metrics, AI-assisted chat, and synchronization with Apple Health.
  • Entropy Biomarker Proprietary wellness biomarker quantifying the real-time metabolic cost of being alive, displayed as a live score from 1 to 250 updated every second, with Entropy Maxima (peak physical capacity) and Entropy Minima (resting metabolic cost) sub-scores.
  • Temple Subscription Services Planned recurring subscription service accompanying the Temple device experience, referenced in the Terms of Use; the beta device payment is applied as a discount toward the eventual commercial subscription price.

Companies that use Temple

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Temple technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature6 records

Temple partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Temple competitors and assessment

Company assessment

Direct peers

  • Polar: Heart rate and performance wearable brand frequently cited in Temple's accuracy benchmarks (e.g., the badminton test). Directly comparable on accuracy-centric positioning in elite sport and the same target buyer profile.
  • Muse: Head-worn brain-sensing wearable (EEG) for meditation, sleep, and focus. Comparable to Temple on head-worn form factor, brain-focused biometrics, and consumer neurotechnology category, with overlap in the 'preventive/cognitive health' value proposition.
  • Whoop: Subscription-based wrist wearable focused on recovery, strain, and sleep for athletes and high-performance users. Directly comparable to Temple in target customer (elite performance), wearable-with-subscription business model, and emphasis on proprietary recovery/biomarker metrics rather than step counting.
  • Oura: Smart ring with subscription that delivers proprietary readiness, sleep, and recovery scores for performance-oriented consumers. Comparable to Temple in hardware-plus-subscription model, proprietary biomarker framing, and premium consumer positioning.

Others

  • Humane (AI Pin): Failed consumer hardware startup that illustrates the risks of premium, design-forward hardware without a clear validated use case. Comparable as a cautionary structural peer for Temple's premium consumer hardware business model and fundraising scale.

Broad incumbents

  • Garmin: Established performance wearables portfolio with deep penetration among elite and endurance athletes. Comparable on target customer (elite athletes including PV Sindhu's broader category) and accuracy validation culture, and a key competitor for sport-specific adoption.
  • Apple Watch: Dominant wrist-worn wearable with health sensors (HR, HRV, SpO2, ECG) and deep Apple Health integration. Represents the incumbent Temple must displace or differentiate from, particularly given Temple's Apple Health sync compatibility.

Emerging players

  • Neurable: Brain-computer interface company building EEG-based wearables for productivity and health. Comparable to Temple on neurotechnology/Brain-Computer Interface focus and the same recruiting areas (neural sensing, EEG).
  • Cranialis: Emerging consumer neurotechnology startup developing head-worn devices for cognitive performance. Thematically adjacent to Temple on head-worn form factor and brain-performance biometrics.

Regional players

  • Ultrahuman: India-based smart ring and metabolic health wearable startup with a premium performance positioning. Comparable as a fellow Indian premium wearable brand targeting high-performance users with proprietary biomarkers; competes in the same Indian premium consumer segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Temple social profiles

Digital presence

Temple financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Temple leadership team

Management profile

Number of profiles

Profiles11 records

Temple subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Temple funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Temple M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Temple

What does Temple do?

Temple develops a head-worn (temple/forehead) wearable device that non-invasively reads the proprietary Entropy biomarker from the superficial temporal artery, quantifying real-time metabolic and sympathetic demand on a 1–250 scale. The hardware is paired with a companion mobile application that visualizes Entropy, heart rate, sleep, recovery and other metrics, integrates with Apple Health, and offers an AI-assisted chat for personalized insights.

Is Temple a public or private company?

Temple is a private company. It is classified as venture growth investor backed and is currently operating.

When was Temple founded?

Temple was founded in 2024. It employs 251 to 500 people.

Where is Temple based?

Temple is headquartered in New Delhi, India, in the Asia region.

How does Temple make money?

Three revenue lines are on record. Device hardware sales are the primary driver. The others are subscription Services and beta device program fees.

Who are Temple's main competitors?

Direct peers on record are Polar, Muse, Whoop and Oura. Humane (AI Pin) is listed as an others. Broad incumbents are Garmin and Apple Watch. Emerging players are Neurable and Cranialis. Ultrahuman is listed as a regional player.

Does Temple have an API?

No public API is recorded for Temple.

What industry is Temple in?

Temple's product category is Wearable Health Technology. Its primary akta.pro industry code is CRACAIAG, Sleep Tech Wearables, with a secondary code of CRACAQAH, Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Indian ExpressTemple and Protocol32: Everything unproven is not pseudoscienceThe author argues that regulation should follow what a product actually claims and does, not merely what its makers call it, citing Temple and Protocol32 as examples. He stresses that early customers are consumers entitled to know what their money buys, and that unproven hypotheses are not automatically pseudoscience.Hindustantimes‘You want to test one for a day?’: Deepinder Goyal lauds man’s laptop experiment mimicking Temple wearableDeepinder Goyal praised a man's LinkedIn experiment that mimicked Temple's microphone-free voice tech using a laptop motion sensor. Goyal revealed Temple uses two high-frequency accelerometers, sampling up to 16kHz on double-tap, and offered the man a day's trial. The wearable has faced controversy over its ₹85,000 price and scientific credibility.The Times of IndiaCopy of Deepinder Goyal's Rs 85,000 Temple: Man attempts to recreate wearable's technology, gets invited by Zomato founder to test the real deviceA venture capitalist attempted to replicate Deepinder Goyal's Temple wearable's vibration-based speech detection using a laptop's accelerometer, but it only worked with slowed-down audio. Goyal explained Temple uses two accelerometers and invited the experimenter to test the device. Temple, priced at Rs 85,000, has faced scrutiny over its health claims.The HinduDeepinder Goyal’s Temple device: Science, Scam or Marketing? | In Focus PodcastA podcast episode examines Deepinder Goyal's Temple wellness tracker, which he claims has robust scientific credentials. Doctors have debunked his claims, calling it a scam. The episode explores the science behind Temple, its accuracy in measuring brain blood flow, and the credibility of Goyal's Gravity Ageing Hypothesis.Inc42Not Just About Temple: India’s Wearable ImpasseTemple, founded by Deepinder Goyal, launched a wearable tracking brain blood flow and entropy, but its metrics lack established validation. The company cites peer-reviewed studies, yet critics question its medical-device classification and regulatory compliance. Goyal plans to publish Entropy findings soon, while the industry awaits a clearer playbook for Indian wearables.Financial ExpressThe claims & the controversies around wearable TempleDoctors questioned Zomato founder Deepinder Goyal's Temple fitness tracker's brain-health claims, citing it measures a scalp-supplying artery. The Rs 85,000 device, which tracks proprietary metrics, faces backlash despite Goyal's defense and $54 million seed round. The Indian smart wearable market is projected to grow from $3.62 billion in 2026 to $12.28 billion by 2032.The TribuneAre wearable devices worth the hype - The TribuneWearable devices like Temple, developed by Zomato's Deepinder Goyal, sparked controversy after experts questioned their medical claims. The device tracks entropy, not cerebral blood flow, and lacks clinical validation. The article highlights regulatory and ethical gaps, urging stronger frameworks for medical and wellness devices.Business News TodayOPINION | Don’t listen to doctors on Temple, or any device like it. Take it from a doctor- Moneycontrol.comA doctor argues that medical professionals should not dismiss Temple, a health wearable, as a scam. He cites Richard Bernstein's story and notes Temple's limited current capabilities, but says AI could eventually extract health insights from its signals. He urges doctors to guide patients on disease while allowing healthy people to pursue personal health goals.Business News TodayWhy Deepinder Goyal’s Temple wearable needs clinically-validated medical evidence- Moneycontrol.comDeepinder Goyal's Temple wearable is at the center of a debate after Dr. Cyriac Abby Philips questioned its scientific basis, calling it a "beautiful scam." Doctors caution that further clinical studies are needed before it can be considered reliable, while Goyal insists the device makes no medical claims and is a fitness + AI product.The IndependentWhy a £700 blood-flow tracker has sparked a clash between Indian billionaire and doctorsIndian billionaire Deepinder Goyal's £700 wearable Temple, claiming to track brain blood flow, has sparked criticism from doctors who say its claims lack peer-reviewed backing. Pre-orders opened on 1 November, and doctors have called it a scam or gimmick, while Goyal defends it as a fitness tracker with emerging science.